Creative human-AI partnerships and AI-generated music: WaveAI CEO and co-founder Maya Ackerman speaks with Jon Krohn about learning to see – and accept – AI’s…
Thought Leader: Jon Krohn
How The Feds Discourage Prescription Drug Competition
July 1, 2015
Source: Link
By Scott Gottlieb (original source Forbes)
“There’s a growing refrain among those who pay for healthcare services that they want new products to deliver more value. When it comes to prescription drugs, this is usually interpreted to mean medicines that provide more benefit, at lower costs per increment of clinical advantage. Drugs that deliver more bang for the buck.
But pharmaceutical competition usually turns on claims of absolute efficacy rather than the relative and comparative merits of a medicine. There is one obvious reason.
Drug companies can rarely make claims around the value of their medicines.”
Click here to read more
Relevant and recent posts
Dr. Sanjay Gupta: How to Safely Store Your Leftovers
We all have our cooking rituals, but are some of them unsafe? Dr. Sanjay Gupta gets to the bottom of handwashing hygiene, especially when handling…
Thought Leader: Sanjay Gupta
Ian Bremmer: “We’re not much closer to a ceasefire”
The Trump administration is pushing to secure a peace deal to end the war in Ukraine. But what that looks like and whether Russia is…
Thought Leader: Ian Bremmer
Recent posts
Jon Krohn: Creative Machines
Thought Leader: Jon Krohn
Dr. Sanjay Gupta: How to Safely Store Your Leftovers
Thought Leader: Sanjay Gupta
Ian Bremmer: “We’re not much closer to a ceasefire”
Thought Leader: Ian Bremmer